CHRS fundamentals
Coherus BioSciences, Inc. revenue breakdown overview
Coherus BioSciences, Inc. revenue for the last year amounted to 266.96 M USD, the most of which — 266.96 M USD — came from its highest performing source at the moment, Human Pharmaceutical Products, the year earlier bringing 257.24 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Coherus BioSciences, Inc. 266.96 M USD, and the year before that — 257.24 M USD.
By source
By country